Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
Clinical trial NCT04121403 · COMPLETED
Trial details
- NCT number
- NCT04121403
- Sponsor
- Oslo University Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-16
- Primary completion
- 2024-08-31
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.